RODMAN&RENSHAW Stock Recommendations and Price Targets

This is a list of recent ratings by RODMAN&RENSHAW.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
11/14/2024
ADIL
Adial Pharmaceuticals
Upgrade$1.00Strong-BuyN/A
11/14/2024
RMTI
Rockwell Medical
Upgrade$2.00Strong-BuyN/A
11/14/2024
EPRX
Eupraxia Pharmaceuticals
Upgrade$3.00Strong-BuyN/A
11/14/2024
ACHV
Achieve Life Sciences
Upgrade$5.00Strong-BuyN/A
11/14/2024
OMER
Omeros
Upgrade$12.00Strong-BuyN/A
11/5/2024
BCAX
Bicara Therapeutics
Upgrade$21.00Strong-BuyLow
10/29/2024
QNCX
Quince Therapeutics
Upgrade$2.00Strong-BuyHigh
10/23/2024
ANRO
Alto Neuroscience
Downgrade$4.00Strong-Buy ➝ HoldMedium
10/9/2024
NKTX
Nkarta
Upgrade$3.00Strong-BuyHigh
10/9/2024
KYTX
Kyverna Therapeutics
Upgrade$5.00Strong-BuyHigh
9/30/2024
MIRA
MIRA Pharmaceuticals
Upgrade$1.00Strong-BuyLow
9/26/2024
BMEA
Biomea Fusion
Upgrade$6.00Strong-BuyLow